N

    Neuronetics Inc (STIM)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $2.94
    -0.02 (-0.68%)

    Market Cap: $224.02M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    64%(21/33)
    Avg Surprise
    -0.41%
    Streak
    3 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.11
    Range$-0.12 - $-0.10
    4 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate Drift
    90d ago$0.00+100.0%
    60d ago$-0.11-0.7%
    30d ago$-0.11-0.7%
    7d ago$-0.11+0.0%
    Current$-0.11
    Revenue Consensus
    $41M
    Range$40M - $43M
    4 analysts
    Dec 31, 2026
    EPS Consensus$-0.06
    Range$-0.06 - $-0.06
    1 analysts
    Revenue Consensus
    $47M
    Range$46M - $47M
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.06---
    Sep 26EST
    		-$-0.11---
    Jun 26
    		$-0.05N/A+54.55%Beat+66.7%
    Mar 26
    		$-0.15$-0.17+11.76%Beat+28.6%
    Dec 25
    		$-0.10$-0.11+9.09%Beat+69.7%
    Sep 25
    		$-0.13$-0.12-8.33%Miss+70.5%
    Jun 25
    		$-0.15$-0.08-87.50%Miss+54.5%
    Mar 25
    		$-0.21$-0.12-75.00%Miss+22.2%
    Dec 24
    		$-0.33$-0.24-37.50%Miss-73.7%
    Sep 24
    		$-0.44$-0.23-91.30%Miss-33.3%
    Jun 24
    		$-0.33$-0.27-22.22%Miss-94.1%
    Mar 24
    		$-0.27$-0.31+12.90%Beat+28.9%
    Dec 23
    		$-0.19$-0.26+26.92%Beat+36.7%
    Sep 23
    		$-0.33$-0.28-17.86%Miss-17.9%
    Jun 23
    		$-0.17N/A+51.43%Beat+56.4%
    Mar 23
    		$-0.38$-0.39+2.56%Beat+7.3%
    Dec 22
    		$-0.30$-0.38+21.05%Beat-3.4%
    Sep 22
    		$-0.28$-0.42+33.33%Beat+9.7%
    Jun 22
    		$-0.39$-0.41+4.88%Beat-34.5%
    Mar 22
    		$-0.41$-0.40-2.50%Miss-32.3%
    Dec 21
    		$-0.29$-0.32+9.38%Beat-52.6%
    Sep 21
    		$-0.31$-0.30-3.33%Miss-72.2%
    Jun 21
    		$-0.29$-0.24-20.83%Miss+29.3%
    Mar 21
    		$-0.31$-0.31+0.00%Beat+50.8%
    Dec 20
    		$-0.19$-0.24+20.83%Beat+53.7%
    Sep 20
    		$-0.18$-0.28+35.71%Beat+51.4%
    Jun 20
    		$-0.41$-0.50+18.00%Beat-5.1%
    Mar 20
    		$-0.63$-0.46-36.96%Miss-50.0%
    Dec 19
    		$-0.41$-0.44+6.82%Beat-17.1%
    Sep 19
    		$-0.37$-0.43+13.95%Beat-27.6%
    Jun 19
    		$-0.39$-0.41+4.88%Beat+41.8%
    Mar 19
    		$-0.42$-0.40-5.00%Miss-2200.0%
    Dec 18
    		$-0.35$-0.37+5.41%Beat-
    Sep 18
    		$-0.29$-0.40+27.50%Beat-
    Jun 18
    		$-0.67$-0.88+23.86%Beat-
    Mar 18
    		$0.02$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-6.84EV/EBITDA-2.02x
    Price/FCF-19.11xFCF Yield-5.23%
    Profitability
    Profit Margin-19.60%Operating Margin-3.61%
    ROE-116.10%ROIC-21.23%
    Financial Health
    Debt/Equity3.46xInterest Coverage-2.26x
    Current Ratio1.88xQuick Ratio1.69x
    Trading Statistics
    Beta1.12Avg Volume2.83M
    52-Week High$3.7152-Week Low$0.80

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$3.04
    SMA 20$2.84
    SMA 50$2.11
    SMA 200$1.67
    EMA 10$2.96
    EMA 20$2.79
    EMA 50$2.32
    EMA 200$2.05

    MACD

    Line: 0.27Signal: 0.31Hist: -0.05

    ADX

    ADX: 45.1+DI: 24.7-DI: 13.9

    Aroon & PSAR

    Aroon Up52.0
    Aroon Down4.0
    PSAR$2.88

    Bollinger Bands

    Upper Band$3.64
    Lower Band$2.04
    %B Position5639%(Upper)
    Band Width0.56

    RSI (14-Day)

    Neutral
    60.2

    Momentum Oscillators

    Stoch %K56.0
    Stoch %D63.7
    Williams %R-68.5
    ROC (10d)-10.9%
    Momentum-0.36
    CCI (20d)22.2
    MFI (14d)79.2

    Volatility Measures

    ATR (14d)$0.23(7.9%)
    StdDev (20d)0.40
    Hist Vol182.3%(High)

    Volume Flow

    VWAP$2.95
    OBV11.5M
    AD Line-36.8M
    CMF (20d)0.141

    Volume Metrics

    Avg Vol (20d)3.0M
    Vol Ratio0.3x(Low)
    VWMA (20d)$3.01

    Pivot Points

    R3$3.13
    R2$3.09
    R1$3.02
    Pivot Point$2.98
    S1$2.91
    S2$2.87
    S3$2.80

    Advanced Oscillators

    TSI30.01
    Ultimate Osc51.1
    KST675.76

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$41.57M$34.45M$41.78M$37.30M$38.11M$31.98M$22.49M$18.53M$16.45M$17.42M$20.31M$17.88M
    Cost of Revenue$20.34M$18.30M$20.07M$20.19M$20.35M$16.24M$7.60M$4.53M$4.27M$4.33M$4.54M$6.12M
    Gross Profit$21.22M$16.15M$21.70M$17.11M$17.76M$15.74M$14.89M$14.00M$12.18M$13.09M$15.77M$11.76M
    Operating Expenses$22.72M$25.15M$26.75M$24.43M$25.82M$26.75M$26.36M$21.73M$20.69M$19.95M$20.20M$20.64M
    R&D$1.34M$1.36M$1.67M$1.50M$1.80M$1.62M$5.77M$2.42M$2.23M$2.35M$2.21M$2.15M
    SG&A$11.40M$13.05M$13.34M$11.08M$12.15M$13.14M$10.78M$7.44M$6.15M$5.96M$6.28M$6.34M
    Operating Income$-1,501,000$-8,995,000$-5,043,000$-7,321,000$-8,058,000$-11,014,000$-11,469,000$-7,728,000$-8,507,000$-6,859,000$-4,427,000$-8,871,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$2.13M$2.81M$2.32M$2.21M$1.97M$1.92M$1.76M$6.15M$1.98M$1.83M$1.84M$1.18M
    Income Before Tax$-3,464,000$-10,780,000$-7,206,000$-9,401,000$-9,839,000$-12,689,000$-12,681,000$-13,341,000$-9,832,000$-7,873,000$-5,377,000$-9,391,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-3,464,000$-10,780,000$-7,206,000$-9,401,000$-9,839,000$-12,689,000$-12,681,000$-13,341,000$-9,832,000$-7,873,000$-5,377,000$-9,391,000
    EBITDA$-388,000$-6,974,000$-3,897,000$-6,097,000$-6,770,000$-9,667,000$-10,287,000$-6,571,000$-6,986,000$-5,326,000$-2,857,000$-7,570,000
    EBIT$-1,339,000$-7,975,000$-4,888,000$-7,195,000$-7,870,000$-10,767,000$-10,924,000$-7,189,000$-7,854,000$-6,047,000$-3,534,000$-8,207,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about STIM

    Government Contracts

    Gov Obligations (TTM)
    $10200
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    3
    New Awards (TTM)
    1
    Avg Remaining Term
    13.5 mo

    Top agency: Department of Defense at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    HT001425PE077Department of DefenseDefense Health Agency$10200Sep 27, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Neuronetics (NASDAQ: STIM) backer spent about $20.7M of his own cash

    Investor Jorey Chernett has updated his Schedule 13D filing for Neuronetics (STIM), reporting a beneficial ownership of 10,602,988 shares, which constitutes approximately 13.92% of the company's common stock. These shares were acquired using his personal funds, totaling about $20.7 million. The amendment primarily reflects an updated ownership percentage due to changes in Neuronetics' outstanding shares, as reported in their recent Form 10-Q.

    Stock Titan•8/25/26•
    Neutral

    Neuronetics | 144: Notice of proposed sale of securities pursuant to Rule 144

    This article is a formal notice regarding the proposed sale of securities by Neuronetics, issued pursuant to Rule 144. It indicates that the company is reporting an intent to sell certain securities as required by regulatory guidelines. The content explicitly states "Document," implying the article itself is a brief notification rather than a detailed report.

    Moomoo•8/20/26•
    Neutral

    Neuronetics (NASDAQ: STIM) ex-officer lines up $464K stock sale

    A former officer of Neuronetics, William A. Macan, has filed to sell 149,891 shares of the company's common stock, valued at approximately $463,934.30, under Rule 144. These shares were acquired on August 14, 2026, through restricted stock vesting as compensation. In the three months prior, Macan had already sold 121,033 shares for about $388,273.87.

    Stock Titan•8/19/26•
    Neutral

    Neuronetics Expands CFO Nir Naor’s Financial Leadership Role

    Neuronetics announced the expansion of CFO Nir Naor's role to include principal financial and accounting officer and corporate secretary, effective August 12, 2026, consolidating key financial and governance functions. This follows the departure of interim officer Francis X. Brown III and aims to enhance leadership stability and regulatory compliance. Despite positive technical signals and operational improvements, Spark, TipRanks' AI Analyst, rates STIM as Neutral due to ongoing financial risks like losses, negative free cash flow, and a leveraged balance sheet.

    The Globe and Mail•8/18/26•
    Neutral

    Neuronetics (NASDAQ: STIM) holder plans $388K sale with part for taxes

    A holder of Neuronetics (NASDAQ: STIM) plans to sell up to 121,033 shares of common stock, valued at approximately $388,273.87, through Fidelity Brokerage Services LLC on NASDAQ. The sale is tied to restricted stock vesting from August 14, 2026, and includes shares designated to cover tax obligations arising from a vested equity award distribution. This transaction is disclosed via a Rule 144 notice, indicating an insider's intent to sell a portion of their holdings.

    Stock Titan•8/18/26•
    Neutral

    Frequently Asked Questions About STIM

    Does STIM pay dividends?
    Neuronetics Inc (STIM) does not currently pay a regular dividend.
    What is STIM's market cap?
    Neuronetics Inc (STIM) has a market capitalization of $224.02M with a current stock price of $2.94.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In